Repotrectinib In Patients (Pts) With Ntrk Fusion-Positive (Ntrk+) Advanced Solid Tumors, Including Nsclc: Update From The Phase I/II Trident-1 Trial
Repotrectinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Repotrectinib In Patients (Pts) With Ntrk Fusion-Positive (Ntrk+) Advanced Solid Tumors, Including Nsclc: Update From The Phase I/II Trident-1 Trial ### Output: Repotrectinib